NASDAQ
Caribou Biosciences, Inc. (CRBU) has a current ratio of 5.71x as of Monday, May 25, 2026. This represents a 47.48% decrease compared to its 12-month average of 10.88x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.